Trials / Completed
CompletedNCT01397916
Indoleamine 2,3-dioxygenase (IDO) Activity in Patients With Chronic Lymphocytic Leukemia (CLL)
The Activity of Indoleamine 2,3-dioxygenase in Patients With Chronic Lymphocytic Leukemia (CLL)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 73 (actual)
- Sponsor
- Tampere University Hospital · Academic / Other
- Sex
- All
- Age
- 15 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
The Activity of Indoleamine 2,3-dioxygenase in patients with Chronic Lymphocytic Leukemia (CLL) is studied.
Detailed description
The Activity of Indoleamine 2,3-dioxygenase in patients with Chronic Lymphocytic Leukemia (CLL)is studied in patients and healthly controls.
Conditions
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2011-07-20
- Last updated
- 2024-04-19
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT01397916. Inclusion in this directory is not an endorsement.